BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 16,070
+150 (0.94%)
At close: Jan 28, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 141.83 billion as of January 29, 2026. Its market cap has increased by 17.00% in one year.
Market Cap
141.83B
Enterprise Value
90.99B
Revenue
18.82B
Ranking
n/a
PE Ratio
19.63
Stock Price
16,070.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 141.83B, a decrease of -26.53%. That is a compound annual growth rate of -7.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 141.83B | 3.23% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Solution | 192.65B |
| Ensol Biosciences | 187.72B |
| CORESTEMCHEMON | 176.33B |
| ViGenCell | 169.94B |
| QuadMedicine | 169.55B |
| TiumBio | 168.05B |
| NovMetaPharma | 151.50B |
| TegoScience | 118.50B |